Brief: Orexo Commences Patent Infringement Litigation Against Sun Pharmaceutical

Orexo AB

14/09/2020 07:09

Sept 14 (Reuters) - Orexo AB  ORX.ST :
    * OREXO COMMENCES PATENT INFRINGEMENT LITIGATION AGAINST SUN
PHARMACEUTICAL
    * EXPECTS INCREASED LEGAL EXPENSES RELATED TO LITIGATION
PROCESS,
WITH MAJORITY OF EXPENSES EXPECTED IN 2021 AND 2022
    * EXPENSES IN 2020 ARE EXPECTED TO BE NON-MATERIAL AND ANY
CHANGES
TO OPEX GUIDANCE WILL BE SHARED IN QUARTERLY REPORTS
    * SAYS HAS FILED PATENT INFRINGEMENT ACTION IN UNITED STATES
DISTRICT COURT FOR DISTRICT OF NEW JERSEY, AGAINST SUN
PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMA GLOBAL FZE, SUN
PHARMA GLOBAL, INC., AND SUN PHARMACEUTICAL INDUSTRIES, INC.
    * LAWSUIT WAS FILED IN RESPONSE TO AN ABBREVIATED NEW DRUG
APPLICATION ("ANDA") FILED BY SUN WITH US FOOD AND DRUG
ADMINISTRATION
    * AIMS TO DEFEND EXCLUSIVITY OF ZUBSOLV

Source text for Eikon:  ID:nWkr6WyBqv 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))